Cart
sales@molnova.com
GRK6-IN-2
GRK6-IN-2
Catalog No. M35570
GRK6-IN-2 is a potent G protein-coupled receptor kinase 6 (GRK6) inhibitor with potential antitumor activity.GRK6-IN-2 has been studied in multiple myeloma.
| Size | Price / USD | Stock | Quantity |
| 5MG | 92 | Get Quote |
|
| 10MG | 155 | Get Quote |
|
| 25MG | 296 | Get Quote |
|
| 50MG | 457 | Get Quote |
|
| 100MG | 672 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGRK6-IN-2
-
Brief Description
-
Description
-
Storage
-
NoteResearch use only, not for human use.
-
Reference1. Uehling DE, et al. Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple Myeloma [published correction appears in J Med Chem. 2022 Jan 13;65(1):886-887]. J Med Chem. 2021;64(15):11129-11147.?
molnova catalog
related products
-
GSK299115A
GSK299115A (GSK-299115A) is a selective ROCK1 Inhibitor. GSK299115A exhibits IC50 of 8nM, 620nM, 560nM for ROCK1, RSK1, p70S6K, respectively.
-
GRK6-IN-1
GRK6-IN-1 (compound 18) is a potent inhibitor of G protein-coupled receptor kinase 6 (GRK6) with an IC50 of 120 nM, and has potential for study in multiple myeloma.
-
Takeda103A
Takeda103A is the GRK2-dependent bovine tubulin oxidation effective inhibitor.
